Literature DB >> 31347085

The burden of influenza in older adults: meeting the challenge.

Jessica Bartoszko1, Mark Loeb2.   

Abstract

Influenza is an acute respiratory infection for which vaccination is our best prevention strategy. Small seasonal changes in circulating influenza viruses (antigenic drift) result in the need for annual influenza vaccination, in which the vaccine formulation is updated to better match the predominant circulating influenza viruses that have undergone important antigenic changes. Although the burden of influenza infection and its complications is the highest in older adults, vaccine effectiveness is the lowest in this vulnerable population. This is largely due to waning of the immune response with age known as "immune senescence", and presents an important, unmet challenge. Possible strategies to tackle this include adjuvant and high-dose vaccines, and herd immunity induced by greater vaccine uptake.

Entities:  

Keywords:  Herd immunity; Infection; Influenza; Vaccination; Vaccine effectiveness; Vaccine efficacy

Year:  2019        PMID: 31347085     DOI: 10.1007/s40520-019-01279-3

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  40 in total

Review 1.  Influenza vaccines: an Asia-Pacific perspective.

Authors:  Lance C Jennings
Journal:  Influenza Other Respir Viruses       Date:  2013-11       Impact factor: 4.380

Review 2.  Influenza in the Asia-Pacific region: Findings and recommendations from the Global Influenza Initiative.

Authors:  Benjamin J Cowling; Saverio Caini; Tawee Chotpitayasunondh; Samsuridjal Djauzi; Salvacion R Gatchalian; Q Sue Huang; Parvaiz A Koul; Ping-Ing Lee; Abdul Razak Muttalif; Stanley Plotkin
Journal:  Vaccine       Date:  2017-01-09       Impact factor: 3.641

3.  Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.

Authors:  Jeffrey C Kwong; Kevin L Schwartz; Michael A Campitelli; Hannah Chung; Natasha S Crowcroft; Timothy Karnauchow; Kevin Katz; Dennis T Ko; Allison J McGeer; Dayre McNally; David C Richardson; Laura C Rosella; Andrew Simor; Marek Smieja; George Zahariadis; Jonathan B Gubbay
Journal:  N Engl J Med       Date:  2018-01-25       Impact factor: 91.245

Review 4.  Influenza Virus: Dealing with a Drifting and Shifting Pathogen.

Authors:  Hyunsuh Kim; Robert G Webster; Richard J Webby
Journal:  Viral Immunol       Date:  2018-01-26       Impact factor: 2.257

Review 5.  Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines.

Authors:  R J Cox; K A Brokstad; P Ogra
Journal:  Scand J Immunol       Date:  2004-01       Impact factor: 3.487

6.  Influenza-associated hospitalizations in the United States.

Authors:  William W Thompson; David K Shay; Eric Weintraub; Lynnette Brammer; Carolyn B Bridges; Nancy J Cox; Keiji Fukuda
Journal:  JAMA       Date:  2004-09-15       Impact factor: 56.272

7.  Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.

Authors:  A Danielle Iuliano; Katherine M Roguski; Howard H Chang; David J Muscatello; Rakhee Palekar; Stefano Tempia; Cheryl Cohen; Jon Michael Gran; Dena Schanzer; Benjamin J Cowling; Peng Wu; Jan Kyncl; Li Wei Ang; Minah Park; Monika Redlberger-Fritz; Hongjie Yu; Laura Espenhain; Anand Krishnan; Gideon Emukule; Liselotte van Asten; Susana Pereira da Silva; Suchunya Aungkulanon; Udo Buchholz; Marc-Alain Widdowson; Joseph S Bresee
Journal:  Lancet       Date:  2017-12-14       Impact factor: 79.321

Review 8.  Deviations in influenza seasonality: odd coincidence or obscure consequence?

Authors:  M Moorthy; D Castronovo; A Abraham; S Bhattacharyya; S Gradus; J Gorski; Y N Naumov; N H Fefferman; E N Naumova
Journal:  Clin Microbiol Infect       Date:  2012-10       Impact factor: 8.067

Review 9.  Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region.

Authors:  Lance Jennings; Qiu Sue Huang; Ian Barr; Ping-Ing Lee; Woo Joo Kim; Philippe Buchy; Melvin Sanicas; Bruce A Mungall; Jing Chen
Journal:  Influenza Other Respir Viruses       Date:  2018-03-07       Impact factor: 4.380

Review 10.  Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis.

Authors:  Dominik Mertz; Tae Hyong Kim; Jennie Johnstone; Po-Po Lam; Michelle Science; Stefan P Kuster; Shaza A Fadel; Dat Tran; Eduardo Fernandez; Neera Bhatnagar; Mark Loeb
Journal:  BMJ       Date:  2013-08-23
View more
  5 in total

1.  Seasonal influenza vaccination among older adults in Jordan: prevalence, knowledge, and attitudes.

Authors:  Mera Ababneh; Mutaz Jaber; Abeer Rababa'h; Faris Ababneh
Journal:  Hum Vaccin Immunother       Date:  2020-02-11       Impact factor: 3.452

2.  The New Quadrivalent Adjuvanted Influenza Vaccine for the Italian Elderly: A Health Technology Assessment.

Authors:  Giovanna Elisa Calabrò; Sara Boccalini; Donatella Panatto; Caterina Rizzo; Maria Luisa Di Pietro; Fasika Molla Abreha; Marco Ajelli; Daniela Amicizia; Angela Bechini; Irene Giacchetta; Piero Luigi Lai; Stefano Merler; Chiara Primieri; Filippo Trentini; Sara Violi; Paolo Bonanni; Chiara de Waure
Journal:  Int J Environ Res Public Health       Date:  2022-03-31       Impact factor: 3.390

3.  The impact of personal coaching on influenza vaccination among healthcare workers before and during COVID-19 pandemic.

Authors:  Shuk-Ching Wong; Veronica Wing-Man Chan; Germaine Kit Ming Lam; Lithia Lai-Ha Yuen; Christine Ho-Yan AuYeung; Xin Li; Jonathan Hon-Kwan Chen; Pui-Hing Chau; Kwok-Yung Yuen; Vincent Chi-Chung Cheng
Journal:  Vaccine       Date:  2022-06-27       Impact factor: 4.169

Review 4.  Nutrition, Immunosenescence, and Infectious Disease: An Overview of the Scientific Evidence on Micronutrients and on Modulation of the Gut Microbiota.

Authors:  Philip C Calder; Edwin Frank Ortega; Simin N Meydani; Yuriko Adkins; Charles B Stephensen; Brice Thompson; Heather Zwickey
Journal:  Adv Nutr       Date:  2022-10-02       Impact factor: 11.567

5.  Safety and immunogenicity of a quadrivalent influenza vaccine in adults aged 60 years or above: a phase III randomized controlled clinical study.

Authors:  Renfeng Fan; Xiaoyuan Huang; Xuanxuan Nian; Zhiqiang Ou; Jian Zhou; Jiayou Zhang; Peiyu Zeng; Wei Zhao; Jinglong Deng; Wei Chen; Shaomin Chen; Kai Duan; Yingshi Chen; Xinguo Li; Jikai Zhang; Xiaoming Yang
Journal:  Hum Vaccin Immunother       Date:  2021-09-02       Impact factor: 3.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.